Distribution of retroviral vectors and vector producer cells using two routes of administration in rats

Gene Therapy

Volumn 6, Issue 8, 1999, Pages 1389-1396

  Kaloss, M ^a   Linscott, M ^a   Wey, C ^a   Lu, P ^a   Long, Z ^a   McGarrity, G J ^a   Otto, E ^a   Lyons, R M ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Gene therapy; Retrovirus; Risk assessment; Vector

Indexed keywords

VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENETIC TRANSDUCTION; GONAD; LUNG; LYMPH NODE; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RETROVIRUS; SKIN; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; FEMALE; GENETIC VECTORS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAVENTRICULAR; LUNG; LYMPH NODES; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED F344; SENSITIVITY AND SPECIFICITY; SIMPLEXVIRUS; SKIN; TESTIS;

EID: 0032858149     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300983     Document Type: Article

References (20)

1. Moolten FL. Tumor chemosensitivity conferred by inserted thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276-5281.
2. Ezzeddine ZD et al. Selective killing of glioma cells in culture and in vivo following retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biologist 1991; 3: 1-7.
3. Miller AD, Rossman G. Improved retroviral vectors for gene transfer and expression. BioTechniques 1989; 7: 980-990.
4. Brown PO. Integration. In: JM Coffin, SH Hughes, HE Varmus (eds). Retrovirnses. Cold Spring Harbor Laboratory Press: NY, 1997, pp 161-203.
5. Luciev PA, Leung NJ. Mechanisms of retrovirus replication. In: Levy JA (ed). The Retroviridae (Viruses), vol. 1. Plenum Press: New York, 1992, pp 159-298.
6. Short MP et al. Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line. J Neurosci Res 1990; 27: 427-439.
7. Ram Z et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nature Med 1997; 3: 1354-1361.
8. Long Z et al. Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells. Hum Gene Ther 1998; 9: 1165-1172.
9. Long Z et al. Molecular evaluation of biopsy and autopsy specimens from patients receiving in vivo retroviral gene therapy. Hum Gene Ther 1999; 10: 733-740.
10. Cosset F-L et al. High titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
11. Rother RP et al. A novel mechanism of retrovirus inactivation in human serum mediated by anti α-galactosyl natural antibody. J Exp Med 1995; 182: 1345-1355.
12. Rother RP, Squinto SP. The α-galactosyl epitope: a sugar coating that makes viruses and cells unpalatable. Cell 1996; 86: 185-188.
13. Lyons RM et al. An improved vector encoding the Herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo. Cancer Gene Ther 1995; 2: 273-280.
14. Finsen BR et al. Leukocyte infiltration and glial reactions in xenografts of mouse brain tissue undergoing rejection in the adult rat brain: a light and electron microscopical immunocytochemical study. J Neuroimmunol 1991; 32: 159-183.
15. Kamantigue E et al. Evidence for localization of biologically active recombinant retroviral vector to lymph nodes in mice injected intramuscularly. Gene Therapy 1996; 3: 128-136.
16. Kotani H, McGarrity GJ. Safe, efficient production of retroviral vectors. In: Oxender DL, Post LE (eds). Handbook of Experimental Pharmacology, vol. 137. Springer-Verlag: New York, 1999.
17. Culver KW et al. In vivo gene transfer with retroviral-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
18. Derelanko MJ. Risk assessment: comparative mammalian organ weights. In: Derelanko MS, Hollinger MA (eds). CRC Handbook of Toxicology. CRC Press: New York, 1995, p 645.
19. Waynforth HB, Flecknell PA. Intracerebral injections. In: Experimental and Surgical Techniques in the Rat, 2nd edn. Academic Press: San Diego, 1992, pp 39-42.
20. Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986; 6: 2895-2902.